evidence: - ^ "Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing Today with U.S. FDA for Emergency Use Authorization". Moderna, Inc. (Press release). 30 November 2020. Archived from the original on 30 November 2020. Retrieved 30 November 2020. [...] - ^ "COVID-19 Vaccine Moderna EPAR". European Medicines Agency (EMA). 4 January 2021. Archived from the original on 12 March 2021. Retrieved 20 January 2021. [...] - ^ "COVID-19 Vaccine Moderna". Union Register of medicinal products. Archived from the original on 24 January 2021. Retrieved 14 January 2021.